OTCMKTS:ACUR - Acura Pharmaceuticals Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$0.4085 +0.02 (+5.15 %)
(As of 06/17/2018 04:00 PM ET)
Previous Close$0.4085
Today's Range$0.2760 - $0.41
52-Week Range$0.2710 - $0.8702
Volume5,993 shs
Average Volume11,128 shs
Market Capitalization$8.59 million
P/E RatioN/A
Dividend YieldN/A
Beta2.52

About Acura Pharmaceuticals (OTCMKTS:ACUR)

Acura Pharmaceuticals logoAcura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.

Receive ACUR News and Ratings via Email

Sign-up to receive the latest news and ratings for ACUR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
SymbolOTCMKTS:ACUR
CUSIP00509L70
Phone847-705-7709

Debt

Debt-to-Equity RatioN/A
Current Ratio0.55
Quick Ratio0.55

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$2.97 million
Price / Sales2.89
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-5,680,000.00
Net Margins-191.57%
Return on Equity-765.25%
Return on Assets-84.33%

Miscellaneous

Employees15
Outstanding Shares21,030,000

Acura Pharmaceuticals (OTCMKTS:ACUR) Frequently Asked Questions

What is Acura Pharmaceuticals' stock symbol?

Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR."

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals (OTCMKTS:ACUR) announced its earnings results on Thursday, June, 7th. The specialty pharmaceutical company reported ($0.08) earnings per share (EPS) for the quarter. The specialty pharmaceutical company had revenue of $0.07 million for the quarter. Acura Pharmaceuticals had a negative net margin of 191.57% and a negative return on equity of 765.25%. View Acura Pharmaceuticals' Earnings History.

What price target have analysts set for ACUR?

0 brokers have issued 1-year price objectives for Acura Pharmaceuticals' shares. Their forecasts range from $0.55 to $0.55. On average, they expect Acura Pharmaceuticals' share price to reach $0.55 in the next twelve months. View Analyst Ratings for Acura Pharmaceuticals.

Who are some of Acura Pharmaceuticals' key competitors?

Who are Acura Pharmaceuticals' key executives?

Acura Pharmaceuticals' management team includes the folowing people:
  • Mr. Robert B. Jones, Pres, CEO & Director (Age 59)
  • Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (Age 65)
  • Dr. Albert W. Brzeczko Ph.D., VP of Technical Affairs (Age 61)
  • Mr. James F. Emigh R.PH., VP of Corp. Devel. (Age 62)
  • Mr. Robert A. Seiser Ph.D., VP, Treasurer & Corp. Controller (Age 54)

Has Acura Pharmaceuticals been receiving favorable news coverage?

Press coverage about ACUR stock has trended somewhat positive recently, according to Accern Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Acura Pharmaceuticals earned a media sentiment score of 0.11 on Accern's scale. They also assigned news coverage about the specialty pharmaceutical company an impact score of 46.61 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near future.

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Acura Pharmaceuticals' stock price today?

One share of ACUR stock can currently be purchased for approximately $0.4085.

How big of a company is Acura Pharmaceuticals?

Acura Pharmaceuticals has a market capitalization of $8.59 million and generates $2.97 million in revenue each year. Acura Pharmaceuticals employs 15 workers across the globe.

How can I contact Acura Pharmaceuticals?

Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The specialty pharmaceutical company can be reached via phone at 847-705-7709 or via email at [email protected]


MarketBeat Community Rating for Acura Pharmaceuticals (ACUR)

Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  137 (Vote Outperform)
Underperform Votes:  102 (Vote Underperform)
Total Votes:  239
MarketBeat's community ratings are surveys of what our community members think about Acura Pharmaceuticals and other stocks. Vote "Outperform" if you believe ACUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACUR will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Acura Pharmaceuticals (OTCMKTS:ACUR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $0.55$0.55$0.58N/A
Price Target Upside: 34.64% upside22.22% upside22.77% downsideN/A

Acura Pharmaceuticals (OTCMKTS:ACUR) Consensus Price Target History

Price Target History for Acura Pharmaceuticals (OTCMKTS:ACUR)

Acura Pharmaceuticals (OTCMKTS:ACUR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/4/2018S&P Equity ResearchBoost Price Target$0.44 ➝ $0.55View Rating Details
10/21/2016FBR & CoReiterated RatingOutperform$10.00View Rating Details
10/18/2016Roth CapitalSet Price TargetBuy$6.00View Rating Details
(Data available from 6/17/2016 forward)

Earnings

Acura Pharmaceuticals (OTCMKTS:ACUR) Earnings History and Estimates Chart

Earnings by Quarter for Acura Pharmaceuticals (OTCMKTS:ACUR)

Acura Pharmaceuticals (OTCMKTS ACUR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
6/7/2018Q4 2017($0.08)$0.07 millionViewN/AView Earnings Details
11/13/2017Q3 2017($0.12)$0.08 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.11)($0.18)$0.09 millionViewN/AView Earnings Details
5/12/2017Q1 2017($0.11)$0.03$0.34 million$2.72 millionViewN/AView Earnings Details
3/31/2017Q4 2016($0.27)$0.13$0.26 million$3.77 millionViewN/AView Earnings Details
11/14/2016Q3($0.27)($0.19)$0.23 million$0.22 millionViewN/AView Earnings Details
8/8/2016Q2($0.28)($0.28)$0.19 million$0.26 millionViewN/AView Earnings Details
5/2/2016Q116($0.26)($0.28)$0.15 million$0.22 millionViewN/AView Earnings Details
2/29/2016Q315($0.03)($0.08)$2.70 million$2.68 millionViewListenView Earnings Details
11/4/2015Q3 2015($0.23)$3.10 million$0.21 millionViewN/AView Earnings Details
8/3/2015Q215($0.02)($0.05)$2.90 million$0.34 millionViewN/AView Earnings Details
5/4/2015Q115$0.07$0.03$7.60 million$5.40 millionViewN/AView Earnings Details
3/2/2015Q414($0.09)($0.06)$0.05 million$0.53 millionViewN/AView Earnings Details
11/3/2014Q3 2014($0.08)($0.06)$0.05 million$0.15 millionViewN/AView Earnings Details
8/4/2014Q2 2014($0.40)($0.35)$0.05 million$0.04 millionViewN/AView Earnings Details
5/5/2014Q1 2014($0.40)$0.04 millionViewN/AView Earnings Details
3/3/2014Q4 13($0.06)($0.29)$0.04 millionViewN/AView Earnings Details
11/4/2013Q3 2013($0.35)($0.35)$0.03 million$0.08 millionViewN/AView Earnings Details
8/1/2013Q2 2013($0.07)ViewN/AView Earnings Details
5/2/2013Q1 2013($0.45)ViewN/AView Earnings Details
3/4/2013Q4 2012($0.86)ViewN/AView Earnings Details
11/6/2012Q3 2012($0.20)ViewN/AView Earnings Details
7/30/2012Q2 2012($0.25)ViewN/AView Earnings Details
5/1/2012Q1 2012($0.25)ViewN/AView Earnings Details
3/5/2012Q4 2011($0.17)ViewN/AView Earnings Details
10/31/2011Q3 2011($0.25)ViewN/AView Earnings Details
7/28/2011Q2 2011$1.78ViewN/AView Earnings Details
4/28/2011Q1 2011($0.31)ViewN/AView Earnings Details
3/1/2011Q4 2010($0.31)ViewN/AView Earnings Details
11/2/2010Q3 2010($0.27)ViewN/AView Earnings Details
7/29/2010Q2 2010($0.34)ViewN/AView Earnings Details
4/21/2010Q1 2010($0.45)ViewN/AView Earnings Details
3/2/2010Q4 2009($0.44)ViewN/AView Earnings Details
10/26/2009Q3 2009($0.43)ViewN/AView Earnings Details
7/30/2009Q2 2009($0.15)($0.71)ViewN/AView Earnings Details
5/1/2009Q1 2009($0.30)($0.14)ViewN/AView Earnings Details
3/2/2009Q4 2008($0.07)ViewN/AView Earnings Details
10/28/2008Q3 2008$0.32ViewN/AView Earnings Details
7/30/2008Q2 2008$1.40ViewN/AView Earnings Details
4/30/2008Q1 2008$0.75ViewN/AView Earnings Details
3/5/2008Q4 2007($0.01)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Acura Pharmaceuticals (OTCMKTS:ACUR) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Acura Pharmaceuticals (OTCMKTS ACUR) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 9.30%
Insider Trading History for Acura Pharmaceuticals (OTCMKTS:ACUR)
Institutional Ownership by Quarter for Acura Pharmaceuticals (OTCMKTS:ACUR)

Acura Pharmaceuticals (OTCMKTS ACUR) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/14/2017Bruce F WessonDirectorBuy335,734$0.10$33,573.40394,404View SEC Filing  
12/14/2017Claudius LlcMajor ShareholderSell2,195,734$0.10$219,573.40View SEC Filing  
12/14/2017Peter A ClemensVPBuy300,000$0.10$30,000.00355,182View SEC Filing  
12/14/2017Robert B JonesInsiderBuy400,000$0.10$40,000.00412,555View SEC Filing  
8/29/2017Albert W BrzeczkoVPBuy10,800$0.47$5,076.006,200View SEC Filing  
6/17/2015Claudius LlcMajor ShareholderSell104,823$1.08$113,208.84View SEC Filing  
1/12/2015Claudius LlcMajor ShareholderSell171,000$0.62$106,020.00View SEC Filing  
5/22/2014William G SkellyDirectorSell4,600$1.23$5,658.00View SEC Filing  
5/20/2014William G SkellyDirectorSell5,000$1.21$6,050.00View SEC Filing  
5/19/2014Albert W BrzeczkoVPBuy2,000$1.20$2,400.00View SEC Filing  
5/16/2014Bruce F WessonDirectorBuy80,000$1.13$90,400.00View SEC Filing  
5/16/2014James F EmighVPBuy15,000$1.21$18,150.00View SEC Filing  
5/16/2014Peter A ClemensCFOBuy3,000$1.21$3,630.00View SEC Filing  
5/14/2014William G SkellyDirectorSell2,900$1.21$3,509.00View SEC Filing  
5/12/2014William G SkellyDirectorSell5,000$1.25$6,250.00View SEC Filing  
5/8/2014William G SkellyDirectorSell2,500$1.30$3,250.00View SEC Filing  
3/3/2014Claudius LlcMajor ShareholderSell2,500$2.00$5,000.00View SEC Filing  
2/28/2014Claudius LlcMajor ShareholderSell351,260$2.02$709,545.20View SEC Filing  
2/24/2014Claudius LlcMajor ShareholderSell44,019$1.97$86,717.43View SEC Filing  
11/25/2013Albert W BrzeczkoVPBuy1,215$1.70$2,065.50View SEC Filing  
10/10/2013Claudius LlcMajor ShareholderSell4,200$2.05$8,610.00View SEC Filing  
8/27/2013William G SkellyDirectorSell2,000$1.55$3,100.00View SEC Filing  
7/15/2013Care Capital Ii LlcMajor ShareholderSell31,610$2.04$64,484.40View SEC Filing  
7/3/2013Care Capital Ii LlcMajor ShareholderSell14,200$2.00$28,400.00View SEC Filing  
7/2/2013Claudius LlcMajor ShareholderSell200,000$2.15$430,000.00View SEC Filing  
6/27/2013Care Capital Ii LlcMajor ShareholderSell76,281$2.01$153,324.81View SEC Filing  
6/24/2013Care Capital Ii LlcMajor ShareholderSell83,000$2.03$168,490.00View SEC Filing  
6/19/2013Care Capital Ii LlcMajor ShareholderSell114,000$2.12$241,680.00View SEC Filing  
6/17/2013Claudius LlcMajor ShareholderSell20,446$2.15$43,958.90View SEC Filing  
6/14/2013Care Capital Ii LlcMajor ShareholderSell90,000$2.16$194,400.00View SEC Filing  
6/11/2013Care Capital Ii LlcMajor ShareholderSell102,000$2.19$223,380.00View SEC Filing  
6/10/2013Claudius LlcMajor ShareholderSell21,496$2.20$47,291.20View SEC Filing  
6/6/2013Claudius LlcMajor ShareholderSell39,453$2.19$86,402.07View SEC Filing  
6/3/2013Care Capital Ii LlcMajor ShareholderSell148,000$2.24$331,520.00View SEC Filing  
5/31/2013Claudius LlcMajor ShareholderSell31,559$2.25$71,007.75View SEC Filing  
5/29/2013Care Capital Ii LlcMajor ShareholderSell108,701$2.33$253,273.33View SEC Filing  
5/28/2013William G SkellyDirectorSell2,000$2.40$4,800.00View SEC Filing  
5/23/2013Care Capital Ii LlcMajor ShareholderSell252,000$2.31$582,120.00View SEC Filing  
5/22/2013William G SkellyDirectorSell4,000$2.33$9,320.00View SEC Filing  
5/21/2013Claudius LlcMajor ShareholderSell47,410$2.30$109,043.00View SEC Filing  
5/20/2013Care Capital Ii LlcMajor ShareholderSell510,000$2.36$1,203,600.00View SEC Filing  
5/16/2013Care Capital Ii LlcMajor ShareholderSell662,000$2.38$1,575,560.00View SEC Filing  
5/16/2013William G SkellyDirectorSell3,000$2.25$6,750.00View SEC Filing  
5/15/2013Claudius LlcMajor ShareholderSell183,434$2.33$427,401.22View SEC Filing  
5/13/2013Care Capital Ii LlcMajor ShareholderSell259,000$2.19$567,210.00View SEC Filing  
5/9/2013William G SkellyDirectorSell3,000$2.20$6,600.00View SEC Filing  
4/11/2013Claudius LlcMajor ShareholderSell121,454$2.23$270,842.42View SEC Filing  
3/26/2013Care Capital Ii LlcMajor ShareholderSell39,554$2.17$85,832.18View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Acura Pharmaceuticals (OTCMKTS ACUR) News Headlines

Source:
DateHeadline
Form 8-K ACURA PHARMACEUTICALS, For: May 15Form 8-K ACURA PHARMACEUTICALS, For: May 15
www.streetinsider.com - May 23 at 8:18 AM
Strongbridge Biopharma (SBBP) and Acura Pharmaceuticals (ACUR) Financial ReviewStrongbridge Biopharma (SBBP) and Acura Pharmaceuticals (ACUR) Financial Review
www.americanbankingnews.com - May 21 at 3:17 PM
Acura Pharmaceuticals (ACUR) Price Target Increased to $0.55 by Analysts at S&P Equity ResearchAcura Pharmaceuticals (ACUR) Price Target Increased to $0.55 by Analysts at S&P Equity Research
www.americanbankingnews.com - May 5 at 2:45 AM
Acura Pharmaceuticals (ACUR) Upgraded to Hold at ValuEngineAcura Pharmaceuticals (ACUR) Upgraded to Hold at ValuEngine
www.americanbankingnews.com - May 4 at 3:35 PM
Head to Head Review: Acura Pharmaceuticals (ACUR) & Johnson & Johnson (JNJ)Head to Head Review: Acura Pharmaceuticals (ACUR) & Johnson & Johnson (JNJ)
www.americanbankingnews.com - May 2 at 11:35 AM
Financial Survey: Acura Pharmaceuticals (ACUR) and ACADIA Pharmaceuticals (ACAD)Financial Survey: Acura Pharmaceuticals (ACUR) and ACADIA Pharmaceuticals (ACAD)
www.americanbankingnews.com - March 20 at 3:19 AM
Global Respiratory Drugs Market Briefing 2018 - Anti-Asthmatics and COPD Drugs, Cough and Cold Preparations - ResearchAndMarkets.comGlobal Respiratory Drugs Market Briefing 2018 - Anti-Asthmatics and COPD Drugs, Cough and Cold Preparations - ResearchAndMarkets.com
www.bizjournals.com - February 3 at 9:22 AM
Acura Pharmaceuticals (ACUR) Price Target Lowered to $0.58 at S&P Equity ResearchAcura Pharmaceuticals (ACUR) Price Target Lowered to $0.58 at S&P Equity Research
www.americanbankingnews.com - January 17 at 5:24 PM
Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301Acura Pharmaceuticals Announces Successful Results from Study AP-LTX-301
finance.yahoo.com - January 17 at 3:38 PM
Global Respiratory Drugs Market Briefing 2017 - Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations ... - Business Wire (press release)Global Respiratory Drugs Market Briefing 2017 - Anti-Asthmatics And COPD Drugs, Cough And Cold Preparations ... - Business Wire (press release)
www.businesswire.com - January 3 at 3:38 PM
Claudius Llc Sells 2,195,734 Shares of Acura Pharmaceuticals, Inc. (ACUR) StockClaudius Llc Sells 2,195,734 Shares of Acura Pharmaceuticals, Inc. (ACUR) Stock
www.americanbankingnews.com - January 3 at 12:30 AM
Acura Pharmaceuticals (ACUR) Raised to "Sell" at ValuEngineAcura Pharmaceuticals (ACUR) Raised to "Sell" at ValuEngine
www.americanbankingnews.com - December 30 at 11:18 AM
Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017Acura Pharmaceuticals, Inc. :ACUR-US: Earnings Analysis: Q3, 2017 By the Numbers : December 25, 2017
finance.yahoo.com - December 25 at 4:18 PM
Acura Pharmaceuticals, Inc. (ACUR) VP Buys $30,000.00 in StockAcura Pharmaceuticals, Inc. (ACUR) VP Buys $30,000.00 in Stock
www.americanbankingnews.com - December 15 at 6:54 PM
Insider Buying: Acura Pharmaceuticals, Inc. (ACUR) Insider Buys 400,000 Shares of StockInsider Buying: Acura Pharmaceuticals, Inc. (ACUR) Insider Buys 400,000 Shares of Stock
www.americanbankingnews.com - December 15 at 6:54 PM
Acura Pharmaceuticals, Inc. (ACUR) Director Buys $33,573.40 in StockAcura Pharmaceuticals, Inc. (ACUR) Director Buys $33,573.40 in Stock
www.americanbankingnews.com - December 15 at 6:54 PM
Head to Head Survey: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) vs. Acura Pharmaceuticals (ACUR)Head to Head Survey: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) vs. Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 14 at 5:40 PM
Financial Review: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Financial Review: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 13 at 7:24 PM
Head-To-Head Review: Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Head-To-Head Review: Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 13 at 3:28 AM
Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Critical SurveyAcura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Critical Survey
www.americanbankingnews.com - December 12 at 3:24 AM
Head-To-Head Contrast: Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Head-To-Head Contrast: Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 11 at 9:30 PM
Reviewing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)Reviewing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 11 at 5:38 AM
Comparing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)Comparing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 10 at 7:20 PM
Financial Survey: Acura Pharmaceuticals (ACUR) versus Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Financial Survey: Acura Pharmaceuticals (ACUR) versus Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 10 at 12:14 PM
Financial Survey: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Financial Survey: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 10 at 3:26 AM
Head to Head Analysis: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Head to Head Analysis: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 9 at 3:14 AM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) versus Acura Pharmaceuticals (ACUR) Critical AnalysisAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) versus Acura Pharmaceuticals (ACUR) Critical Analysis
www.americanbankingnews.com - December 7 at 7:46 PM
Contrasting Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)Contrasting Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 7 at 5:30 PM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR) Financial ContrastAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR) Financial Contrast
www.americanbankingnews.com - December 6 at 11:31 PM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) vs. Acura Pharmaceuticals (ACUR) Head to Head AnalysisAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) vs. Acura Pharmaceuticals (ACUR) Head to Head Analysis
www.americanbankingnews.com - December 6 at 11:30 PM
Comparing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Comparing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 6 at 7:26 PM
Head-To-Head Contrast: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Head-To-Head Contrast: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 5 at 3:32 AM
Comparing Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Comparing Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - December 4 at 7:42 PM
Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Financial ContrastAcura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Financial Contrast
www.americanbankingnews.com - December 1 at 5:40 AM
Analyzing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Analyzing Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - December 1 at 3:34 AM
Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR) Head to Head ReviewAvadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR) Head to Head Review
www.americanbankingnews.com - November 29 at 10:08 PM
Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Head-To-Head ComparisonAcura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Head-To-Head Comparison
www.americanbankingnews.com - November 29 at 7:30 AM
Head-To-Head Survey: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Head-To-Head Survey: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 28 at 5:20 PM
Reviewing Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)Reviewing Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL)
www.americanbankingnews.com - November 28 at 7:56 AM
Head to Head Review: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)Head to Head Review: Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) & Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 27 at 11:44 PM
Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Head to Head ContrastAcura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (AVDL) Head to Head Contrast
www.americanbankingnews.com - November 27 at 11:26 AM
Head-To-Head Contrast: Avadel Pharmaceuticals (AVDL) versus Acura Pharmaceuticals (ACUR)Head-To-Head Contrast: Avadel Pharmaceuticals (AVDL) versus Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 26 at 4:14 AM
Head-To-Head Analysis: Avadel Pharmaceuticals (AVDL) and Acura Pharmaceuticals (ACUR)Head-To-Head Analysis: Avadel Pharmaceuticals (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 26 at 3:48 AM
Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals PLC. (AVDL) Head to Head ReviewAcura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals PLC. (AVDL) Head to Head Review
www.americanbankingnews.com - November 24 at 3:56 AM
Acura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals PLC. (AVDL) Financial ContrastAcura Pharmaceuticals (ACUR) and Avadel Pharmaceuticals PLC. (AVDL) Financial Contrast
www.americanbankingnews.com - November 23 at 1:30 AM
Financial Review: Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals PLC. (AVDL)Financial Review: Acura Pharmaceuticals (ACUR) vs. Avadel Pharmaceuticals PLC. (AVDL)
www.americanbankingnews.com - November 21 at 1:34 PM
Contrasting Avadel Pharmaceuticals PLC. (AVDL) and Acura Pharmaceuticals (ACUR)Contrasting Avadel Pharmaceuticals PLC. (AVDL) and Acura Pharmaceuticals (ACUR)
www.americanbankingnews.com - November 20 at 3:46 PM
Analyzing Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals PLC. (AVDL)Analyzing Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals PLC. (AVDL)
www.americanbankingnews.com - November 19 at 5:52 AM
Acura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals PLC. (AVDL) Head to Head SurveyAcura Pharmaceuticals (ACUR) & Avadel Pharmaceuticals PLC. (AVDL) Head to Head Survey
www.americanbankingnews.com - November 15 at 1:24 AM

SEC Filings

Acura Pharmaceuticals (OTCMKTS:ACUR) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Acura Pharmaceuticals (OTCMKTS:ACUR) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Acura Pharmaceuticals (OTCMKTS ACUR) Stock Chart for Sunday, June, 17, 2018

Loading chart…

This page was last updated on 6/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.